These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 358039)

  • 21. [Current concepts in the pathogenesis and treatment of abortion and septic shock. II. The physiopathological bases and outlook in the management of septic shock].
    Figueroa Damian R; Arredondo García JL
    Ginecol Obstet Mex; 1993 Dec; 61():337-43. PubMed ID: 8119603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Septic shock: a clinical perspective.
    Iverson RL
    Crit Care Clin; 1988 Apr; 4(2):215-28. PubMed ID: 3048584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological treatment of sepsis.
    Girbes AR; Beishuizen A; Strack van Schijndel RJ
    Fundam Clin Pharmacol; 2008 Aug; 22(4):355-61. PubMed ID: 18705746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotics and endotoxic shock.
    McCabe WR
    Bull N Y Acad Med; 1975 Oct; 51(9):1084-95. PubMed ID: 1058731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The definition of septic shock: implications for treatment.
    Marik PE; Lipman J
    Crit Care Resusc; 2007 Mar; 9(1):101-3. PubMed ID: 17352674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure to implement evidence-based clinical guidelines for sepsis at the ED.
    De Miguel-Yanes JM; Andueza-Lillo JA; González-Ramallo VJ; Pastor L; Muñoz J
    Am J Emerg Med; 2006 Sep; 24(5):553-9. PubMed ID: 16938593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An essay regarding pathogenesis and treatment of shock due to bacteremia with special reference to "gram-negative" shock.
    Waisbren BA
    Prog Cardiovasc Dis; 1967 Sep; 10(2):123-33. PubMed ID: 6048070
    [No Abstract]   [Full Text] [Related]  

  • 28. Impact of underlying diseases on the clinical characteristics and outcome of primary pyomyositis.
    Chiu SK; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2008 Aug; 41(4):286-93. PubMed ID: 18787734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Guidelines of hemodynamic monitor and support in adult patients with severe sepsis and septic shock (draft)].
    Society of Critical Care Medicine, Chinese Medical Association
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Mar; 19(3):129-33. PubMed ID: 17376262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations.
    Balk RA
    Dis Mon; 2004 Apr; 50(4):168-213. PubMed ID: 15133467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Common TNF-alpha, IL-1 beta, PAI-1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis.
    Jessen KM; Lindboe SB; Petersen AL; Eugen-Olsen J; Benfield T
    BMC Infect Dis; 2007 Sep; 7():108. PubMed ID: 17877801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Physiopathology, clinical aspects and therapy of shock in meningococcic sepsis].
    Simeoni S; Altieri T; Pacitti C; Mingrino F
    Recenti Prog Med; 1976 Feb; 60(2):131-54. PubMed ID: 790494
    [No Abstract]   [Full Text] [Related]  

  • 33. Epidemiology, pathophysiology and clinical presentation of gram-negative sepsis.
    Hazinski MF; Iberti TJ; MacIntyre NR; Parker MM; Tribett D; Prion S; Chmel H
    Am J Crit Care; 1993 May; 2(3):224-35; quiz 236-7. PubMed ID: 8364674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urgent care in gynaecology: resuscitation and management of sepsis and acute blood loss.
    Fischerova D
    Best Pract Res Clin Obstet Gynaecol; 2009 Oct; 23(5):679-90. PubMed ID: 19596611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nosocomial bacteremia caused by Serratia marcescens: analysis of 44 cases].
    Domínguez A; Arribas JR; Folgueira MD; Peña P; Luengo S; Peña JM; Vázquez JJ
    Enferm Infecc Microbiol Clin; 1990 Nov; 8(9):553-9. PubMed ID: 2099856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology and treatment of gram-negative sepsis.
    DiPiro JT
    Am J Hosp Pharm; 1990 Nov; 47(11 Suppl 3):S6-10. PubMed ID: 2275478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors and pathogenic significance of severe sepsis and septic shock in 2286 patients with gram-negative bacteremia.
    Kang CI; Song JH; Chung DR; Peck KR; Ko KS; Yeom JS; Ki HK; Son JS; Lee SS; Kim YS; Jung SI; Kim SW; Chang HH; Ryu SY; Kwon KT; Lee H; Moon C;
    J Infect; 2011 Jan; 62(1):26-33. PubMed ID: 21056057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current understanding of mechanisms and treatment of circulatory shock caused by bacterial infections.
    Weil M
    Ann Clin Res; 1977 Jun; 9(3):181-91. PubMed ID: 356716
    [No Abstract]   [Full Text] [Related]  

  • 39. Isoproterenol in the treatment of shock due to bacteremia with gram-negative pathogens.
    Kardos GG
    N Engl J Med; 1966 Apr; 274(16):868-73. PubMed ID: 17926865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gram-negative bacteremic shock: pathophysiology, clinical features, and treatment.
    Gleckman R; Esposito A
    South Med J; 1981 Mar; 74(3):335-41. PubMed ID: 7221635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.